{"id":"https://openalex.org/W2944052125","doi":"https://doi.org/10.2147/btt.s199862","title":"Systematic review of immunomodulatory therapies for hidradenitis suppurativa","display_name":"Systematic review of immunomodulatory therapies for hidradenitis suppurativa","publication_year":2019,"publication_date":"2019-05-01","ids":{"openalex":"https://openalex.org/W2944052125","doi":"https://doi.org/10.2147/btt.s199862","mag":"2944052125","pmid":"https://pubmed.ncbi.nlm.nih.gov/31190730","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6526329"},"language":"en","primary_location":{"id":"doi:10.2147/btt.s199862","doi":"https://doi.org/10.2147/btt.s199862","is_oa":true,"landing_page_url":"https://doi.org/10.2147/btt.s199862","pdf_url":"https://www.dovepress.com/getfile.php?fileID=49834","source":{"id":"https://openalex.org/S177732258","display_name":"Biologics","issn_l":"1177-5475","issn":["1177-5475","1177-5491"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologics: Targets and Therapy","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=49834","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087262330","display_name":"Shi Yu Derek Lim","orcid":"https://orcid.org/0000-0002-7079-2416","observed_orcids":["https://orcid.org/0000-0002-7079-2416"]},"institutions":[{"id":"https://openalex.org/I4405257834","display_name":"National Healthcare Group","ror":"https://ror.org/05qkemg93","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I4405257834"]}],"countries":["SG"],"is_corresponding":true,"raw_author_name":"Shi Yu Derek Lim","raw_affiliation_strings":["Internal Medicine Residency, National Healthcare Group, Singapore, Singapore"],"raw_orcid":"https://orcid.org/0000-0002-7079-2416","affiliations":[{"raw_affiliation_string":"Internal Medicine Residency, National Healthcare Group, Singapore, Singapore","institution_ids":["https://openalex.org/I4405257834"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002050242","display_name":"Hazel Hwee Boon Oon","orcid":"https://orcid.org/0000-0001-7607-3124","observed_orcids":["https://orcid.org/0000-0001-7607-3124"]},"institutions":[{"id":"https://openalex.org/I1287551835","display_name":"National Skin Centre","ror":"https://ror.org/000p7hm12","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I1287551835"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Hazel H Oon","raw_affiliation_strings":["Department of Dermatology, National Skin Centre, Singapore, Singapore"],"raw_orcid":"https://orcid.org/0000-0001-7607-3124","affiliations":[{"raw_affiliation_string":"Department of Dermatology, National Skin Centre, Singapore, Singapore","institution_ids":["https://openalex.org/I1287551835"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5087262330"],"corresponding_institution_ids":["https://openalex.org/I4405257834"],"apc_list":{"value":2320,"currency":"USD","value_usd":2320},"apc_paid":{"value":2320,"currency":"USD","value_usd":2320},"fwci":1.8852,"has_fulltext":true,"cited_by_count":63,"citation_normalized_percentile":{"value":0.85959438,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"Volume 13","issue":null,"first_page":"53","last_page":"78"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12731","display_name":"Hidradenitis Suppurativa and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12731","display_name":"Hidradenitis Suppurativa and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12328","display_name":"Autoimmune and Inflammatory Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13328","display_name":"Osteomyelitis and Bone Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hidradenitis-suppurativa","display_name":"hidradenitis suppurativa","score":1.0},{"id":"https://openalex.org/keywords/immunomodulatory-therapy","display_name":"immunomodulatory therapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.7039999961853027},{"id":"https://openalex.org/keywords/tumor-necrosis-factor-inhibitors","display_name":"tumor necrosis factor inhibitors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.8629999756813049},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":1.0},{"id":"https://openalex.org/keywords/secukinumab","display_name":"secukinumab","score":0.968999981880188},{"id":"https://openalex.org/keywords/il-17-inhibitors","display_name":"IL-17 inhibitors","score":0.7009999752044678},{"id":"https://openalex.org/keywords/il-23-inhibitors","display_name":"IL-23 inhibitors","score":0.8320000171661377},{"id":"https://openalex.org/keywords/anakinra","display_name":"anakinra","score":0.8040000200271606},{"id":"https://openalex.org/keywords/ustekinumab","display_name":"ustekinumab","score":0.9789999723434448},{"id":"https://openalex.org/keywords/bimekizumab","display_name":"bimekizumab","score":0.8140000104904175},{"id":"https://openalex.org/keywords/apremilast","display_name":"apremilast","score":0.7409999966621399},{"id":"https://openalex.org/keywords/canakinumab","display_name":"canakinumab","score":0.7540000081062317},{"id":"https://openalex.org/keywords/golimumab","display_name":"golimumab","score":0.8669999837875366},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9649999737739563},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6019999980926514},{"id":"https://openalex.org/keywords/infection-risk","display_name":"infection risk","score":0.4659999907016754}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9448204040527344},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.8252121806144714},{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.7959407567977905},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.7210114002227783},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.7123079895973206},{"id":"https://openalex.org/C2778975655","wikidata":"https://www.wikidata.org/wiki/Q420305","display_name":"Ustekinumab","level":4,"score":0.6571910381317139},{"id":"https://openalex.org/C2781290027","wikidata":"https://www.wikidata.org/wiki/Q413879","display_name":"Golimumab","level":4,"score":0.6536316871643066},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6205281615257263},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6124396324157715},{"id":"https://openalex.org/C2776002364","wikidata":"https://www.wikidata.org/wiki/Q341999","display_name":"Hidradenitis suppurativa","level":3,"score":0.5418127775192261},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5324769020080566},{"id":"https://openalex.org/C2781427535","wikidata":"https://www.wikidata.org/wiki/Q2858961","display_name":"Apremilast","level":4,"score":0.5187630653381348},{"id":"https://openalex.org/C2779725882","wikidata":"https://www.wikidata.org/wiki/Q3655009","display_name":"Canakinumab","level":4,"score":0.4955853223800659},{"id":"https://openalex.org/C2781228260","wikidata":"https://www.wikidata.org/wiki/Q415411","display_name":"Anakinra","level":3,"score":0.4793549180030823},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4682560861110687},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3621750771999359},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.22426527738571167},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.19023728370666504},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.11717760562896729}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.2147/btt.s199862","doi":"https://doi.org/10.2147/btt.s199862","is_oa":true,"landing_page_url":"https://doi.org/10.2147/btt.s199862","pdf_url":"https://www.dovepress.com/getfile.php?fileID=49834","source":{"id":"https://openalex.org/S177732258","display_name":"Biologics","issn_l":"1177-5475","issn":["1177-5475","1177-5491"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologics: Targets and Therapy","raw_type":"journal-article"},{"id":"pmid:31190730","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31190730","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologics : targets & therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6526329","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6526329/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologics","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:ff7ff9ad9eff4c3380960a44698e56b2","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ff7ff9ad9eff4c3380960a44698e56b2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Biologics: Targets & Therapy, Vol Volume 13, Pp 53-78 (2019)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/45796","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/systematic-review-of-immunomodulatory-therapies-for-hidradenitis-suppu-peer-reviewed-article-BTT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"}],"best_oa_location":{"id":"doi:10.2147/btt.s199862","doi":"https://doi.org/10.2147/btt.s199862","is_oa":true,"landing_page_url":"https://doi.org/10.2147/btt.s199862","pdf_url":"https://www.dovepress.com/getfile.php?fileID=49834","source":{"id":"https://openalex.org/S177732258","display_name":"Biologics","issn_l":"1177-5475","issn":["1177-5475","1177-5491"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologics: Targets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2944052125.pdf","grobid_xml":"https://content.openalex.org/works/W2944052125.grobid-xml"},"referenced_works_count":127,"referenced_works":["https://openalex.org/W22854913","https://openalex.org/W1487695212","https://openalex.org/W1521486523","https://openalex.org/W1532825733","https://openalex.org/W1538494537","https://openalex.org/W1572159617","https://openalex.org/W1632579585","https://openalex.org/W1791162777","https://openalex.org/W1812621612","https://openalex.org/W1855788659","https://openalex.org/W1873931639","https://openalex.org/W1907413284","https://openalex.org/W1917790641","https://openalex.org/W1948492302","https://openalex.org/W1970251850","https://openalex.org/W1972616335","https://openalex.org/W1980685745","https://openalex.org/W1983763840","https://openalex.org/W1994586850","https://openalex.org/W1995086092","https://openalex.org/W1997485142","https://openalex.org/W2004015573","https://openalex.org/W2006127139","https://openalex.org/W2010493468","https://openalex.org/W2018608147","https://openalex.org/W2027056608","https://openalex.org/W2027907732","https://openalex.org/W2030049258","https://openalex.org/W2031313786","https://openalex.org/W2032126510","https://openalex.org/W2033249972","https://openalex.org/W2038988798","https://openalex.org/W2040010013","https://openalex.org/W2041193055","https://openalex.org/W2041374605","https://openalex.org/W2044656306","https://openalex.org/W2046617659","https://openalex.org/W2048764846","https://openalex.org/W2056718732","https://openalex.org/W2058922227","https://openalex.org/W2060474375","https://openalex.org/W2061956731","https://openalex.org/W2066313343","https://openalex.org/W2066896272","https://openalex.org/W2067405236","https://openalex.org/W2067775822","https://openalex.org/W2068176248","https://openalex.org/W2071893776","https://openalex.org/W2079563843","https://openalex.org/W2088744925","https://openalex.org/W2098105262","https://openalex.org/W2102196816","https://openalex.org/W2106953569","https://openalex.org/W2109443005","https://openalex.org/W2110047792","https://openalex.org/W2120037509","https://openalex.org/W2120236484","https://openalex.org/W2125570183","https://openalex.org/W2126637727","https://openalex.org/W2127799105","https://openalex.org/W2128583237","https://openalex.org/W2130804808","https://openalex.org/W2132353895","https://openalex.org/W2137963102","https://openalex.org/W2139130283","https://openalex.org/W2146549230","https://openalex.org/W2149717883","https://openalex.org/W2155840434","https://openalex.org/W2158193558","https://openalex.org/W2160965670","https://openalex.org/W2161626606","https://openalex.org/W2161769425","https://openalex.org/W2163545413","https://openalex.org/W2165385798","https://openalex.org/W2166041394","https://openalex.org/W2166542375","https://openalex.org/W2172171511","https://openalex.org/W2172208853","https://openalex.org/W2175027747","https://openalex.org/W2192166578","https://openalex.org/W2196652401","https://openalex.org/W2206641590","https://openalex.org/W2308253435","https://openalex.org/W2401325601","https://openalex.org/W2413286833","https://openalex.org/W2503109448","https://openalex.org/W2528101119","https://openalex.org/W2550814440","https://openalex.org/W2554542667","https://openalex.org/W2581930879","https://openalex.org/W2606470589","https://openalex.org/W2615949569","https://openalex.org/W2653859450","https://openalex.org/W2694182897","https://openalex.org/W2725200785","https://openalex.org/W2736915451","https://openalex.org/W2742869577","https://openalex.org/W2752045615","https://openalex.org/W2755789752","https://openalex.org/W2767283105","https://openalex.org/W2767737860","https://openalex.org/W2768337579","https://openalex.org/W2778320654","https://openalex.org/W2783879982","https://openalex.org/W2785647181","https://openalex.org/W2793177567","https://openalex.org/W2793527685","https://openalex.org/W2794845062","https://openalex.org/W2801584235","https://openalex.org/W2801882643","https://openalex.org/W2804545769","https://openalex.org/W2805791571","https://openalex.org/W2806696712","https://openalex.org/W2807103028","https://openalex.org/W2809995844","https://openalex.org/W2811395800","https://openalex.org/W2894720168","https://openalex.org/W2895487699","https://openalex.org/W2895616269","https://openalex.org/W2896283288","https://openalex.org/W2903291109","https://openalex.org/W2904815943","https://openalex.org/W2945792041","https://openalex.org/W2992902362","https://openalex.org/W3024966801","https://openalex.org/W3149402525","https://openalex.org/W4200558553"],"related_works":["https://openalex.org/W2767117873","https://openalex.org/W4391601949","https://openalex.org/W7214730646","https://openalex.org/W4205104424","https://openalex.org/W4220871749","https://openalex.org/W4392239472","https://openalex.org/W2564344834","https://openalex.org/W2892738629","https://openalex.org/W4224949919","https://openalex.org/W6944139564"],"abstract_inverted_index":{"Background:":[0],"Greater":[1],"understanding":[2],"of":[3,6,40,96,124,257],"the":[4,13,38,56,81,111,122,179,194,202,251],"roles":[5],"tumor":[7,103,263],"necrosis":[8,104,264],"factor-\u03b1,":[9],"IL-1\u03b2,":[10],"IL-10,":[11],"and":[12,17,58,76,92,108,130,135,155,165,172,188,206,226,233,243,255],"IL-23/T-helper":[14],"(Th)":[15],"17":[16],"IL-12/Th1":[18],"pathways":[19],"in":[20,23,30,80,159],"immune":[21],"dysregulation":[22],"moderate/severe":[24],"hidradenitis":[25],"suppurativa":[26],"(HS)":[27],"has":[28,198],"helped":[29],"developing":[31],"new":[32],"regimens.":[33],"We":[34],"aim":[35],"to":[36,45,65,221,236,249],"review":[37],"use":[39],"different":[41],"immunomodulatory":[42],"therapies":[43],"used":[44,158,235],"manage":[46],"HS.":[47,210],"Methods:":[48],"A":[49],"comprehensive":[50],"literature":[51],"search":[52,88],"was":[53],"conducted":[54],"on":[55],"PubMed":[57],"Clinicaltrials.gov":[59],"databases":[60],"from":[61,118],"1":[62],"January":[63],"1947":[64],"31":[66],"December":[67],"2018.":[68],"Only":[69],"clinical":[70,94,119,230],"trials,":[71,95],"case":[72,74],"reports,":[73],"series":[75],"retrospective":[77],"analyses":[78],"published":[79],"English":[82],"language":[83],"were":[84,110],"included.":[85],"Results:":[86],"Our":[87],"yielded":[89],"107":[90],"articles":[91],"35":[93],"which":[97,197],"15":[98],"are":[99,149,169,247],"still":[100],"ongoing.":[101],"The":[102],"factor-\u03b1":[105],"inhibitors":[106],"adalimumab":[107,192],"infliximab":[109],"most":[112,180],"comprehensively":[113],"studied":[114],"agents.":[115],"Published":[116],"data":[117,246],"trials":[120,138,219],"support":[121],"efficacy":[123,256],"adalimumab,":[125,266],"infliximab,":[126,267],"anakinra,":[127],"ustekinumab,":[128],"bermekimab":[129],"apremilast":[131],"but":[132],"not":[133],"etanercept":[134],"MEDI8968.":[136],"Clinical":[137],"for":[139,151,209],"CJM112":[140],"have":[141],"been":[142,199],"completed,":[143],"with":[144,178,217],"results":[145],"awaiting":[146],"publication.":[147],"Trials":[148],"underway":[150,220],"secukinumab,":[152],"IFX-1,":[153],"INCB054707":[154],"bimekizumab.":[156],"Biologics":[157],"smaller":[160],"cohorts":[161],"include":[162],"canakinumab,":[163],"golimumab":[164],"rituximab.":[166],"Most":[167],"agents":[168,213],"well":[170],"tolerated":[171],"demonstrate":[173],"a":[174],"good":[175],"safety":[176,227,253],"profile,":[177],"commonly":[181],"reported":[182],"adverse":[183],"event":[184],"being":[185],"infections.":[186],"Discussion":[187],"conclusions:":[189],"To":[190],"date,":[191],"is":[193],"only":[195],"biologic":[196],"approved":[200],"by":[201],"United":[203],"States":[204],"Food":[205],"Drug":[207],"Administration":[208],"However,":[211],"other":[212],"also":[214],"show":[215],"promise,":[216],"further":[218],"evaluate":[222,250],"their":[223],"efficacy,":[224],"tolerability":[225],"profiles.":[228],"Different":[229],"measurement":[231],"scores":[232],"endpoints":[234],"make":[237],"direct":[238],"comparison":[239],"difficult.":[240],"Longitudinal":[241],"surveillance":[242],"pooled":[244],"registry":[245],"paramount":[248],"long-term":[252],"profile":[254],"therapy.":[258],"Keywords:":[259],"Hidradenitis":[260],"suppurativa,":[261],"biologics,":[262],"factor,":[265],"secukinumab":[268]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":4},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-05-16T00:00:00"}